Unlocking hope: Promising treatments for cognitive impairment in HIV patients on the horizon
Researchers examine the mechanisms responsible for the increased risk of neurocognitive impairment in HIV patients and explore potential treatments.
Researchers examine the mechanisms responsible for the increased risk of neurocognitive impairment in HIV patients and explore potential treatments.
The effects of potentially modifiable risk factors on dementia vary among people of South Asian, Black, and White ethnicities.
BioLizard, the bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life sciences industry, today announced the launch of its new BioVerse platform.
Researchers at Queen Mary University of London’s Precision Healthcare Research Institute (PHURI) and the Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin have identified the genetic causes of…
Scalpels with built-in sensors could streamline training for surgeons and pave the way for procedures performed by robotic devices, a study suggests.
OrganaBio, the Contract Technology Development and Manufacturing Organization (CTDMO) specializing in solutions for cell and immunotherapy development, today announces the official launch of Cell Processing and Cryopreservation (CPC) Services, a…
The University of Manchester has marked World Mental Health Day today (10 October) with the launch of a new publication offering insight on the causes and challenges of poor mental…
Physical activity has positive effects on mental health and yet, activity rates are declining. This is particularly worrying because the mental well-being of teenagers continues to deteriorate. In the US,…
University of Virginia researchers are working to outrace two dangerous germs known for quickly developing resistance to new antibiotics – and the scientists’ efforts could help us better combat antibiotic…
Analysis of the online conversations among patients with Parkinson’s Disease suggests a need for pharmaceutical research to be targeted at treating the non-motor symptoms of the disease.